DE69219801T2 - 9-Aminotetrahydroakridinederivate und verwandte Derivate, Verfahren zur ihrer Herstellung und ihre Anwendung als Arzneimittel - Google Patents

9-Aminotetrahydroakridinederivate und verwandte Derivate, Verfahren zur ihrer Herstellung und ihre Anwendung als Arzneimittel

Info

Publication number
DE69219801T2
DE69219801T2 DE69219801T DE69219801T DE69219801T2 DE 69219801 T2 DE69219801 T2 DE 69219801T2 DE 69219801 T DE69219801 T DE 69219801T DE 69219801 T DE69219801 T DE 69219801T DE 69219801 T2 DE69219801 T2 DE 69219801T2
Authority
DE
Germany
Prior art keywords
hydrogen
derivatives
loweralkyl
preparation
aminotetrahydroacridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69219801T
Other languages
English (en)
Other versions
DE69219801D1 (de
Inventor
Gregory Michael Shutske
Kevin James Kapples
John Dick Tomer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of DE69219801D1 publication Critical patent/DE69219801D1/de
Application granted granted Critical
Publication of DE69219801T2 publication Critical patent/DE69219801T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • C07D219/10Nitrogen atoms attached in position 9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/12Organo silicon halides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69219801T 1991-02-13 1992-02-12 9-Aminotetrahydroakridinederivate und verwandte Derivate, Verfahren zur ihrer Herstellung und ihre Anwendung als Arzneimittel Expired - Fee Related DE69219801T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/654,691 US5210087A (en) 1991-02-13 1991-02-13 9-aminotetrahydroacridines and related compounds

Publications (2)

Publication Number Publication Date
DE69219801D1 DE69219801D1 (de) 1997-06-26
DE69219801T2 true DE69219801T2 (de) 1997-11-27

Family

ID=24625869

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69219801T Expired - Fee Related DE69219801T2 (de) 1991-02-13 1992-02-12 9-Aminotetrahydroakridinederivate und verwandte Derivate, Verfahren zur ihrer Herstellung und ihre Anwendung als Arzneimittel

Country Status (25)

Country Link
US (3) US5210087A (de)
EP (1) EP0499231B1 (de)
JP (1) JPH07121915B2 (de)
KR (1) KR100223132B1 (de)
AT (1) ATE153331T1 (de)
AU (1) AU664165B2 (de)
BR (1) BR9200475A (de)
CA (1) CA2061084A1 (de)
CZ (1) CZ281927B6 (de)
DE (1) DE69219801T2 (de)
DK (1) DK0499231T3 (de)
ES (1) ES2102417T3 (de)
FI (2) FI96308C (de)
GR (1) GR3024310T3 (de)
HU (1) HU219451B (de)
IE (1) IE920459A1 (de)
IL (3) IL100921A (de)
MX (1) MX9200607A (de)
NO (1) NO177933C (de)
NZ (3) NZ260694A (de)
PL (6) PL168862B1 (de)
RO (1) RO112354B1 (de)
RU (1) RU2083564C1 (de)
TW (1) TW221426B (de)
ZA (1) ZA921004B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210087A (en) * 1991-02-13 1993-05-11 Hoechst-Roussel Pharmaceuticals Inc. 9-aminotetrahydroacridines and related compounds
ES2059263B1 (es) * 1992-10-27 1995-10-01 Vita Invest Sa Procedimiento para la obtencion del (+)-9-amino-1,2,3,4-tetrahidroacridin-1-ol.
US5434170A (en) * 1993-12-23 1995-07-18 Andrulis Pharmaceuticals Corp. Method for treating neurocognitive disorders
ES2144353B1 (es) * 1997-12-26 2001-01-01 Consejo Superior Investigacion Nuevos analogos de tacrina: potenciales agentes neuroprotectores para las enfermedades de alzheimer y parkinson. su procedimiento de obtencion.
EP1484325B1 (de) * 2002-03-08 2014-06-18 Japan Science and Technology Agency Isoxazolderivate und verfahren zu deren herstellung
RU2616247C1 (ru) * 2016-03-28 2017-04-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинский государственный университет имени Коста Левановича Хетагурова" (СОГУ) Твердая лекарственная форма, обладающая холинопозитивным действием, на основе 9-бутиламино-3,3-диметил-1,2,4-тригидроакридина

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232945A (en) * 1962-08-13 1966-02-01 S E Massengill Company 7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines
EP0179383B1 (de) * 1984-10-25 1991-05-29 Hoechst-Roussel Pharmaceuticals Incorporated 9-Amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte Verbindungen, Verfahren zu ihrer Herstellung und Verwendung als Arzneimittel
US4631286A (en) * 1984-10-25 1986-12-23 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
US4695573A (en) * 1984-10-25 1987-09-22 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
WO1989002739A1 (en) * 1987-10-05 1989-04-06 Pfizer Inc. 4-aminopyridine derivatives
GB8827704D0 (en) * 1988-11-28 1988-12-29 Fujisawa Pharmaceutical Co New acridine derivatives & processes for their production
US5441727A (en) * 1989-06-21 1995-08-15 The Procter & Gamble Company Diketone deodorant composition and method of deodorization
US5053513A (en) * 1990-03-29 1991-10-01 Hoechst-Roussel Pharmaceuticals Incorporated Method of reducing a carbonyl containing acridine
US5210087A (en) * 1991-02-13 1993-05-11 Hoechst-Roussel Pharmaceuticals Inc. 9-aminotetrahydroacridines and related compounds
GB2264707A (en) * 1991-06-18 1993-09-08 Roger Michael Marchbanks Acridine derivatives for treating alzheimer's disease

Also Published As

Publication number Publication date
ES2102417T3 (es) 1997-08-01
DE69219801D1 (de) 1997-06-26
GR3024310T3 (en) 1997-10-31
JPH07121915B2 (ja) 1995-12-25
HU9200423D0 (en) 1992-04-28
FI97056B (fi) 1996-06-28
CA2061084A1 (en) 1992-08-14
NO920547L (no) 1992-08-14
US5382594A (en) 1995-01-17
AU664165B2 (en) 1995-11-09
FI97056C (fi) 1996-10-10
EP0499231A1 (de) 1992-08-19
JPH04312578A (ja) 1992-11-04
RO112354B1 (ro) 1997-08-29
EP0499231B1 (de) 1997-05-21
CZ281927B6 (cs) 1997-04-16
FI96308B (fi) 1996-02-29
NO920547D0 (no) 1992-02-12
RU2083564C1 (ru) 1997-07-10
TW221426B (de) 1994-03-01
PL168153B1 (pl) 1996-01-31
FI920566A (fi) 1992-08-14
DK0499231T3 (da) 1997-12-01
US5502203A (en) 1996-03-26
PL166939B1 (pl) 1995-07-31
FI920566A0 (fi) 1992-02-11
AU1090392A (en) 1992-08-20
PL168861B1 (pl) 1996-04-30
FI945854A0 (fi) 1994-12-13
ATE153331T1 (de) 1997-06-15
BR9200475A (pt) 1992-10-20
CS42692A3 (en) 1992-09-16
FI96308C (fi) 1996-06-10
PL296320A1 (en) 1993-07-12
ZA921004B (en) 1992-10-28
NZ260694A (en) 1996-02-27
IL117795A0 (en) 1996-08-04
NZ241586A (en) 1996-02-27
US5210087A (en) 1993-05-11
FI945854A (fi) 1994-12-13
PL168862B1 (pl) 1996-04-30
MX9200607A (es) 1992-11-30
KR100223132B1 (ko) 1999-10-15
KR920016426A (ko) 1992-09-24
IE920459A1 (en) 1992-08-12
NO177933C (no) 1995-12-20
PL293443A1 (en) 1993-03-08
IL117795A (en) 1998-01-04
HUT67032A (en) 1995-01-30
PL168906B1 (pl) 1996-05-31
HU219451B (hu) 2001-04-28
NO177933B (no) 1995-09-11
PL296319A1 (en) 1993-07-12
IL100921A (en) 1998-12-27
PL169095B1 (pl) 1996-05-31
NZ270647A (en) 1996-02-27

Similar Documents

Publication Publication Date Title
DE3772905D1 (de) Alpha-alkyl-4-amino-3-chinolin-methanole und 1-(4-aralkylamino-3-chinolyl)alkanone, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE69219801D1 (de) 9-Aminotetrahydroakridinederivate und verwandte Derivate, Verfahren zur ihrer Herstellung und ihre Anwendung als Arzneimittel
IL92233A0 (en) 1,2,3,4-tetrahydro-1,9-acridinediamines,a process for their preparation and their use as pharmaceutical compositions
DE68914600D1 (de) Kondensierte heterocyclische Derivate von 1,2,3,4-Tetrahydroacridin, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament.
AU619985B2 (en) 4,5,5a,6-tetrahydro-3h-isoxazolo(5,4,3-kl)acridines derivatives, a process for their preparation and their use as medicaments

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee